发明名称 DERIVATIVES OF AZOLE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF ELICITING ACTIVITY WITH RESPECT TO SEROTONIN 5-HT1Dalpha-
摘要 FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to derivatives of benzimidazole of the formula (I) HT1Dalpha where <EMI ID=0.1 HE=33 WI=75 TI=CHI> - H, R1, R7-alkyl, C1-6-alkoxy-group; C1-6 - H, R2, R3, R6, R11, R12-alkyl; C1-6 - H or halogen atom; m, p each = 0, 1 or 2; n = 2; Z means R4, R5, -O-, -S-, <EMI ID=0.2 HE=10 WI=10 TI=CHI>; <EMI ID=0.3 HE=10 WI=16 TI=CHI> - H, R9, R10-alkyl or phenyl-C1-6-alkyl; X - oxygen atom; Y means the residue of the formula (a) C1-6 or (b) <EMI ID=0.4 HE=20 WI=16 TI=CHI>; - H; their salts or solvates showing activity with respect to serotonin 5-<EMI ID=0.5 HE=20 WI=16 TI=CHI>-receptors and can be used for treatment of patients with obesity, bulimia, alcoholism, pains, depression. EFFECT: improved method of synthesis, valuable pharmacological properties. 8 cl, 12 ex
申请公布号 RU2146256(C1) 申请公布日期 2000.03.10
申请号 RU19950115522 申请日期 1995.09.11
申请人 LILLI INDASTRIZ LIMITED 发明人 DZHEREMI DZHILMOR;PITER TADDEUSH GALLAGER;MARTIN VIKTOR MAJLZ;VILL'JAM MARTIN OUTON;KOLIN VILL'JAM SMIT
分类号 C07D403/04;A61K31/405;A61K31/415;A61K31/4164;A61K31/42;A61K31/425;A61K31/455;A61K31/47;A61P1/00;A61P1/08;A61P3/04;A61P9/00;A61P9/12;A61P13/02;A61P15/00;A61P25/00;A61P25/04;A61P25/20;A61P25/24;A61P25/26;A61P25/28;A61P25/30;A61P43/00;C07D209/00;C07D413/06;C07D471/04;C07D487/04;(IPC1-7):C07D403/04 主分类号 C07D403/04
代理机构 代理人
主权项
地址